JP2023528016A5 - - Google Patents

Info

Publication number
JP2023528016A5
JP2023528016A5 JP2022573137A JP2022573137A JP2023528016A5 JP 2023528016 A5 JP2023528016 A5 JP 2023528016A5 JP 2022573137 A JP2022573137 A JP 2022573137A JP 2022573137 A JP2022573137 A JP 2022573137A JP 2023528016 A5 JP2023528016 A5 JP 2023528016A5
Authority
JP
Japan
Prior art keywords
nucleic acid
nucleotides
acid according
chain
strand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022573137A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023528016A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/064077 external-priority patent/WO2021239825A1/en
Publication of JP2023528016A publication Critical patent/JP2023528016A/ja
Publication of JP2023528016A5 publication Critical patent/JP2023528016A5/ja
Pending legal-status Critical Current

Links

JP2022573137A 2020-05-27 2021-05-26 細胞におけるｃｎｎｍ４の発現を阻害するための核酸 Pending JP2023528016A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP20382449.5 2020-05-27
EP20382449 2020-05-27
EP20382947.8 2020-10-30
EP20382947 2020-10-30
PCT/EP2021/064077 WO2021239825A1 (en) 2020-05-27 2021-05-26 Nucleic acids for inhibiting expression of cnnm4 in a cell

Publications (2)

Publication Number Publication Date
JP2023528016A JP2023528016A (ja) 2023-07-03
JP2023528016A5 true JP2023528016A5 (https=) 2024-05-31

Family

ID=76355448

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022573137A Pending JP2023528016A (ja) 2020-05-27 2021-05-26 細胞におけるｃｎｎｍ４の発現を阻害するための核酸

Country Status (7)

Country Link
US (1) US20240229041A2 (https=)
EP (1) EP4158023A1 (https=)
JP (1) JP2023528016A (https=)
KR (1) KR20230018429A (https=)
AU (1) AU2021281511A1 (https=)
CA (1) CA3184050A1 (https=)
WO (1) WO2021239825A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024013334A1 (en) * 2022-07-15 2024-01-18 Silence Therapeutics Gmbh Nucleic acids for inhibiting expression of agt in a cell
JPWO2024172057A1 (https=) * 2023-02-15 2024-08-22

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9201440A (nl) 1992-08-11 1994-03-01 Univ Leiden Triantennaire clusterglycosiden, hun bereiding en toepassing.
EP3228326A1 (en) 2016-04-05 2017-10-11 Silence Therapeutics GmbH Nucleic acid linked to a trivalent glycoconjugate
WO2018185253A1 (en) * 2017-04-05 2018-10-11 Silence Therapeutics Gmbh Ligand modified double-stranded nucleic acids
WO2020109316A1 (en) * 2018-11-26 2020-06-04 Asociación Centro De Investigación Cooperativa En Biociencias-Cic Biogune Methods for diagnosing and/or treating acute or chronic liver, kidney or lung disease

Similar Documents

Publication Publication Date Title
Streicher Exploring the future of infectious disease treatment in a post-antibiotic era: A comparative review of alternative therapeutics
TWI880645B (zh) 抑制lpa之基因表現之組合物及方法
JP2021502120A5 (https=)
JP2022523467A5 (https=)
JP2006525796A5 (https=)
TW201922264A (zh) 用於抑制類血管生成素蛋白-3(ANGPTL3)表現的RNAi藥劑及組合物及使用方法
JP2021533804A5 (https=)
JP2022527108A5 (https=)
JP2019504112A5 (https=)
JP2019531763A5 (https=)
JP2024535888A5 (https=)
JP2018520685A5 (https=)
JP2020530442A5 (https=)
CN100400045C (zh) 基于核酸的化合物及其使用方法
JP2018529732A5 (https=)
JP2023528016A5 (https=)
JP2018523668A5 (https=)
IL274611B2 (en) Nucleic acids for inhibiting expression of a target gene comprising phosphorodithioate linkages
JP2021520207A5 (https=)
JP2019088329A5 (https=)
JP2022520986A5 (https=)
JP2023519518A5 (https=)
JP2024516356A5 (https=)
JP2022513111A5 (https=)
JP2024536146A5 (https=)